摘要
生物医药依赖于高度发达的生物制药技术,专利制度对于生物医药产业的创新激励发挥着至关重要的作用。通过考察美国专利制度变革历程,从先发明制,到临时专利申请,再到《发明法案》变革后的发明人先申请制,分析其对美国生物医药产业的创新性影响,为我们建立促进生物药创新机制提供制度借鉴与参考。
Biomedicine relies on highly developed biopharmaceutical technology and the patent system plays a vital role in stimulating the innovation of biomedicine industry.By investigating the reform process of the patent system in the United States,which from the first inventor-file rule,to the provisional patent application,and then to the first inventor to file after the reform of the American Invention Act.This paper analyzes its innovative impact on the biomedical industry in the United States,and provides institutional reference and reference for us to establish the mechanism of promoting the innovation of biological drugs.
作者
陈庆
蒋鸣娜
张世联
CHEN Qing;JIANG Mingna;ZHANG Shilian(Institute of Health Economic Management,Nanjing University of Chinese Medicine,Nanjing 210023;Changzhou Qinghang Intellectual Property Service Co.,Ltd.,Changzhou 213116;Jiangsu Softwareworks Technology Research Institute Co.,Ltd.,Wuxi 214100)
出处
《中国发明与专利》
2020年第11期6-10,共5页
China Invention & Patent
基金
2016年国家社科基金重大项目(项目编号:16ZDA236)基金资助。
关键词
生物药
发明人先申请制
专利制度
创新性
biological durgs
first inventor to file system
patent system
innovative